34th Annual Chemotherapy Foundation Symposium : Innovative Cancer Therapy for Tomorrow
In-Person Event
Nov 09 - 11, 2016
New York, New York, USA
OVERVIEW
34th Annual Chemotherapy Foundation Symposium : Innovative Cancer Therapy for Tomorrow is organized by Physicians Education Resource, LLC (PER) and would be held During Nov 09 - 11, 2016 at New York Marriott Marquis, New York city, New York, United States of America.
The target audience for this medical oncologists and hematologists interested in the treatment of patients with cancer. Radiotherapists, immunologists, fellows, nurse practitioners, nurses, physician assistants, researchers, case managers, and other health care professionals interested in the treatment of cancer are also invited to attend.
State-of-the-art cancer care continues to evolve due to advances in all aspects of patient care - including diagnosis, and personalized treatment and management. This CME conference has been approved with 22.0 AMA PRA Category 1 Credits.
Educational Objectives :
Upon completion of this activity, participants should be better prepared to :
• Report practice-changing results from clinical trials that impact evolving treatment paradigms in hematologic and solid tumor management
• Outline testing methods for prognostic and predictive markers that inform personalized care strategies in the treatment of cancer
• Discuss optimized chemotherapeutic, targeted, and immunotherapy strategies based on clinical trial evidence
• Describe methods to monitor efficacy and manage treatment-related adverse events in multiple lines of cancer management
• Place recent clinical trial findings in the context of evolving treatment pathways to improve care for patients with cancer.
The target audience for this medical oncologists and hematologists interested in the treatment of patients with cancer. Radiotherapists, immunologists, fellows, nurse practitioners, nurses, physician assistants, researchers, case managers, and other health care professionals interested in the treatment of cancer are also invited to attend.
State-of-the-art cancer care continues to evolve due to advances in all aspects of patient care - including diagnosis, and personalized treatment and management. This CME conference has been approved with 22.0 AMA PRA Category 1 Credits.
Educational Objectives :
Upon completion of this activity, participants should be better prepared to :
• Report practice-changing results from clinical trials that impact evolving treatment paradigms in hematologic and solid tumor management
• Outline testing methods for prognostic and predictive markers that inform personalized care strategies in the treatment of cancer
• Discuss optimized chemotherapeutic, targeted, and immunotherapy strategies based on clinical trial evidence
• Describe methods to monitor efficacy and manage treatment-related adverse events in multiple lines of cancer management
• Place recent clinical trial findings in the context of evolving treatment pathways to improve care for patients with cancer.
KEY DATES
09 Nov, 2016
Event Start Date
11 Nov, 2016
Event End Date
SPECIALITIES
OncologyRadiologyRadiation OncologySUGGESTED HOTELS
CONFERENCE VENUE
New York Marriott MarquisRELATED CONFERENCES & LIVE WEBINARS
Quick Links